Explore our materials

Filters

Results (5253)

Slideset

HIV

INTEREST 2016

Men who have sex with men in sub-Saharan Africa | Iliassou Mfochive Njindam, MD, MPH

Slideset

HIV

INTEREST 2016

(Abstract) Finding the first 90% to achieve epidemic control | J. Masedza

Slideset

HIV

INTEREST 2016

Drug Use in sub-Saharan Africa: opportunities and challenges | Reychad Abdool, MD

Slideset

HIV

INTEREST 2016

Sex work in sub-Saharan Africa | Isidore Traoré, MD, PhD

Slideset

HIV

INTEREST 2016

Prevention Tools: Implementation and Discovery | Cissy Kityo, MD

Slideset

HIV

INTEREST 2016

Update on HIV vaccine strategies and trials: Active and passive immunization strategies | Hannah Kibuuka, MD

Slideset

HIV

INTEREST 2016

(Abstract) Accumulation of HIV-1 drug resistance after continued virological failure on first-line antiretroviral therapy in adults and children | T.S.Boender

Slideset

HIV

INTEREST 2016

(Abstract) Tenofovir-containing first-line ART favourably reduce inflammation markers compared to thymidine analogue nucleoside reverse-transcriptase inhibitors | S. Kroeze

Slideset

HIV

INTEREST 2016

(Abstract) EDCTP as a model for Europe-Africa partnership on HIV/AIDS research and capacity development: Examples from Cameroon | L.J. Pandya

Slideset

HIV

INTEREST 2016

Trial, post-trial, & demonstration project results for Pre-exposure Prophylaxis (PrEP) | Elizabeth Irungu, MBChB, MPH

Slideset

HIV

INTEREST 2016

(Abstract) Predictors of HIV-testing in South African adolescents: schools-based testing, pregnancy and sexual experience | C. Carty

Stephen Watiti

Slideset

HIV

INTEREST 2016

Explore our materials

Your Selection Clear All

Topic

Material Type

Men who have sex with men in sub-Saharan Africa | Iliassou Mfochive Njindam, MD, MPH

(Abstract) Finding the first 90% to achieve epidemic control | J. Masedza

Drug Use in sub-Saharan Africa: opportunities and challenges | Reychad Abdool, MD

Sex work in sub-Saharan Africa | Isidore Traoré, MD, PhD

Prevention Tools: Implementation and Discovery | Cissy Kityo, MD

Update on HIV vaccine strategies and trials: Active and passive immunization strategies | Hannah Kibuuka, MD

(Abstract) Accumulation of HIV-1 drug resistance after continued virological failure on first-line antiretroviral therapy in adults and children | T.S.Boender

(Abstract) Tenofovir-containing first-line ART favourably reduce inflammation markers compared to thymidine analogue nucleoside reverse-transcriptase inhibitors | S. Kroeze

(Abstract) EDCTP as a model for Europe-Africa partnership on HIV/AIDS research and capacity development: Examples from Cameroon | L.J. Pandya

Trial, post-trial, & demonstration project results for Pre-exposure Prophylaxis (PrEP) | Elizabeth Irungu, MBChB, MPH

(Abstract) Predictors of HIV-testing in South African adolescents: schools-based testing, pregnancy and sexual experience | C. Carty

Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PreP) Implementation | Community Advocate | Stephen Watiti, MD